RLMD Competitors & Alternatives
Compare Relmada Therapeutics Inc with similar stocks in the same industry
Biotechnology
RLMD
Main Stock$5.31
Tradestie Score
49
Market Cap
$71.69M
Analyst Upside
+138.5%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTMX
CytomX Therapeutics, Inc.
|
$3.10
|
$552.46M | - | 49 | Compare |
|
VSTM
Verastem, Inc.
|
$5.80
|
$541.60M | - | 53 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$13.26
|
$540.97M | - | 50 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$9.51
|
$529.35M | 4.9 | 55 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$108.35
|
$522.78M | - | 51 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.31
|
$512.39M | - | 53 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$36.81
|
$505.12M | 2.0 | 58 | Compare |
|
FULC
Fulcrum Therapeutics, Inc. Common Stock
|
$3.58
|
$504.67M | - | 48 | Compare |
|
RGNX
REGENXBIO Inc.
|
$9.69
|
$493.52M | - | 50 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$82.05
|
$492.21M | - | 50 | Compare |
More RLMD Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry